These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27318552)

  • 21. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
    J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2.
    Leopoldo M; Lacivita E; Contino M; Colabufo NA; Berardi F; Perrone R
    J Med Chem; 2007 Aug; 50(17):4214-21. PubMed ID: 17649988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of 1-[2-(4-[(11)C]methoxyphenyl)phenyl]piperazine for imaging of the serotonin 5-HT7 receptor in the rat brain.
    Shimoda Y; Yui J; Xie L; Fujinaga M; Yamasaki T; Ogawa M; Nengaki N; Kumata K; Hatori A; Kawamura K; Zhang MR
    Bioorg Med Chem; 2013 Sep; 21(17):5316-22. PubMed ID: 23830697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of spacer structure on 5-HT7 and 5-HT1A receptor affinity in the group of long-chain arylpiperazine ligands.
    Bojarski AJ; Duszyńska B; Kołaczkowski M; Kowalski P; Kowalska T
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5863-6. PubMed ID: 15501057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder.
    Lacivita E; Niso M; Mastromarino M; Garcia Silva A; Resch C; Zeug A; Loza MI; Castro M; Ponimaskin E; Leopoldo M
    ACS Chem Neurosci; 2021 Apr; 12(8):1313-1327. PubMed ID: 33792287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT
    Perry CK; Casey AB; Felsing DE; Vemula R; Zaka M; Herrington NB; Cui M; Kellogg GE; Canal CE; Booth RG
    Bioorg Med Chem; 2020 Feb; 28(3):115262. PubMed ID: 31882369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-basicity 5-HT
    Hogendorf AS; Hogendorf A; Kurczab R; Satała G; Lenda T; Walczak M; Latacz G; Handzlik J; Kieć-Kononowicz K; Wierońska JM; Woźniak M; Cieślik P; Bugno R; Staroń J; Bojarski AJ
    Sci Rep; 2017 May; 7(1):1444. PubMed ID: 28473721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.
    Zhuang ZP; Kung MP; Mu M; Kung HF
    J Med Chem; 1998 Jan; 41(2):157-66. PubMed ID: 9457239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin 5-HT7 receptor agonist, LP-211, exacerbates Na(+), K(+)-ATPase/Mg(2+)-ATPase imbalances in spinal cord-injured male rats.
    Norouzi-Javidan A; Javanbakht J; Barati F; Fakhraei N; Mohammadi F; Dehpour AR
    Diagn Pathol; 2015 Sep; 10():157. PubMed ID: 26369408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LP-211, a selective 5-HT
    Beaudet G; Paizanis E; Zoratto F; Lacivita E; Leopoldo M; Freret T; Laviola G; Boulouard M; Adriani W
    Synapse; 2017 Dec; 71(12):. PubMed ID: 28752923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux.
    Huang M; Horiguchi M; Felix AR; Meltzer HY
    Neuroreport; 2012 May; 23(7):436-40. PubMed ID: 22415605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid-supported synthesis, molecular modeling, and biological activity of long-chain arylpiperazine derivatives with cyclic amino acid amide fragments as 5-HT(7) and 5-HT(1A) receptor ligands.
    Canale V; Guzik P; Kurczab R; Verdie P; Satała G; Kubica B; Pawłowski M; Martinez J; Subra G; Bojarski AJ; Zajdel P
    Eur J Med Chem; 2014 May; 78():10-22. PubMed ID: 24675176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MF-8, a novel promising arylpiperazine-hydantoin based 5-HT
    Latacz G; Lubelska A; Jastrzębska-Więsek M; Partyka A; Kucwaj-Brysz K; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Bioorg Med Chem Lett; 2018 Mar; 28(5):878-883. PubMed ID: 29439902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards novel 5-HT7versus 5-HT1A receptor ligands among LCAPs with cyclic amino acid amide fragments: design, synthesis, and antidepressant properties. Part II.
    Canale V; Kurczab R; Partyka A; Satała G; Witek J; Jastrzębska-Więsek M; Pawłowski M; Bojarski AJ; Wesołowska A; Zajdel P
    Eur J Med Chem; 2015 Mar; 92():202-11. PubMed ID: 25555143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1-aryl-4-[(5-methoxy-1,2,3, 4-tetrahydronaphthalen-1-yl)alkyl]piperazines and their analogues: influence of the stereochemistry of the tetrahydronaphthalen-1-yl nucleus on 5-HT1A receptor affinity and selectivity versus alpha1 and D2 receptors. 5.
    Perrone R; Berardi F; Colabufo NA; Leopoldo M; Tortorella V
    J Med Chem; 1999 Feb; 42(3):490-6. PubMed ID: 9986719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT₁A and 5-HT₇ receptor ligands.
    Modica MN; Intagliata S; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1427-30. PubMed ID: 25759032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and structure-activity relationships of a new model of arylpiperazines. 1. 2-[[4-(o-methoxyphenyl)piperazin-1-yl]methyl]-1, 3-dioxoperhydroimidazo[1,5-alpha]pyridine: a selective 5-HT1A receptor agonist.
    López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Sanz AM; Orensanz L; Beneitez ME; Fuentes JA; Manzanares J
    J Med Chem; 1996 Oct; 39(22):4439-50. PubMed ID: 8893838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver 5-HT7 receptors: A novel regulator target of fibrosis and inflammation-induced chronic liver injury in vivo and in vitro.
    Polat B; Halici Z; Cadirci E; Karakus E; Bayir Y; Albayrak A; Unal D
    Int Immunopharmacol; 2017 Feb; 43():227-235. PubMed ID: 28043031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.
    Handzlik J; Bojarski AJ; Satała G; Kubacka M; Sadek B; Ashoor A; Siwek A; Więcek M; Kucwaj K; Filipek B; Kieć-Kononowicz K
    Eur J Med Chem; 2014 May; 78():324-39. PubMed ID: 24691057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective agonists for serotonin 7 (5-HT7) receptor and their applications in preclinical models: an overview.
    Di Pilato P; Niso M; Adriani W; Romano E; Travaglini D; Berardi F; Colabufo NA; Perrone R; Laviola G; Lacivita E; Leopoldo M
    Rev Neurosci; 2014; 25(3):401-15. PubMed ID: 24622785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.